Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture
暂无分享,去创建一个
[1] M. Palkovits,et al. Decreased central and peripheral catecholaminergic activation in obese Zucker rats. , 1995, Endocrinology.
[2] G. Kingsley,et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.
[3] M. Raichle,et al. Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.
[4] G. Chrousos,et al. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. , 1996, The Journal of clinical endocrinology and metabolism.
[5] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[6] J. Richter,et al. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. , 1994, The American journal of medicine.
[7] G. Chrousos,et al. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. , 1997, The Journal of clinical endocrinology and metabolism.
[8] S. Paul,et al. CSF corticotropin-releasing hormone in depressed patients and normal control subjects. , 1987, The American journal of psychiatry.
[9] G. Chrousos,et al. Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features , 1995, Clinical endocrinology.
[10] S. Kasper,et al. Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. , 1991, The Journal of clinical endocrinology and metabolism.
[11] D. Papanicolaou,et al. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.
[12] G. Chrousos,et al. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. , 1994, Endocrine reviews.
[13] G. Mauceri,et al. Rat hypothalamic corticotropin-releasing hormone secretion is stimulated by interleukin-1 in an eicosanoid-dependent manner. , 1990, Pharmacological research.
[14] G. Chrousos,et al. Arachidonic acid metabolites modulate rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1989, Neuroendocrinology.
[15] G. Chrousos,et al. Introduction: The Concept of Stress and Its Historical Development , 1988 .
[16] E. Bass,et al. Clinical Characteristics of Women With a History of Childhood Abuse: Unhealed Wounds , 1997 .
[17] G. Chrousos,et al. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.
[18] G. Chrousos,et al. Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration: A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States , 1993 .
[19] G. Chrousos,et al. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.
[20] G. Chrousos,et al. Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. , 1996, Endocrine journal.
[21] D. Boumpas,et al. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.
[22] A Luger,et al. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. , 1987, The New England journal of medicine.
[23] G. Chrousos,et al. Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. , 1994, Neuroimmunomodulation.
[24] J. Calabrese,et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. , 1986, The New England journal of medicine.
[25] G. Chrousos. The Future of Pediatric and Adolescent Endocrinology , 1997, Annals of the New York Academy of Sciences.
[26] G. Chrousos,et al. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions , 1997, Molecular Psychiatry.
[27] G. Chrousos,et al. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. , 1997, The Journal of clinical endocrinology and metabolism.
[28] G. Chrousos,et al. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. , 1996, Endocrine reviews.
[29] D. Swaab,et al. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.
[30] G. Chrousos,et al. Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner. , 1990, Life sciences.
[31] G. Chrousos,et al. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.
[32] G. Chrousos,et al. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , 1993, The Journal of clinical investigation.
[33] G. Chrousos,et al. The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. , 1993, Metabolism: clinical and experimental.
[34] J. Csernansky,et al. Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Chrousos,et al. Syndromes of Glucocorticoid Resistance , 1993, Annals of Internal Medicine.
[36] G. Chrousos,et al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. , 1995, Endocrinology.
[37] F. Goodwin,et al. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.
[38] J. Calabrese,et al. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. , 1991, The Journal of clinical endocrinology and metabolism.
[39] P. Munson,et al. The maternal hypothalamic–pituitary–adrenal axis in the third trimester of human pregnancy , 1996, Clinical endocrinology.
[40] G. Chrousos,et al. Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance. , 1988, The Journal of clinical endocrinology and metabolism.
[41] G. Chrousos,et al. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. , 1994, The Journal of clinical endocrinology and metabolism.
[42] G. Chrousos,et al. Bone mineral density in women with depression. , 1996, The New England journal of medicine.
[43] C. Mantzoros,et al. Human leptin levels are pulsatile and inversely related to pituitary–ardenal function , 1997, Nature Medicine.
[44] D. Papanicolaou,et al. The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.
[45] A. Baum,et al. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. , 1993 .
[46] M. Demitrack,et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.
[47] D. Papanicolaou,et al. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. , 1997, Neuroendocrinology.
[48] M. Merino,et al. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. , 1994, The Journal of clinical endocrinology and metabolism.
[49] G. Chrousos,et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. , 1994, The Journal of clinical endocrinology and metabolism.
[50] S. Pillemer,et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.
[51] G. Chrousos,et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. , 1997, The Journal of clinical endocrinology and metabolism.